KEYNOTE-013: An open-label, multicohort phase Ib trial of pembrolizumab in patients with advanced hematologic malignancies Meeting Abstract


Authors: Kline, J.; Armand, P.; Kuruvilla, J.; Moskowitz, C.; Hamadani, M.; Ribrag, V.; Zinzani, P. L.; Chlosta, S.; Thompson, S.; Balakumaran, A.; Bartlett, N.
Abstract Title: KEYNOTE-013: An open-label, multicohort phase Ib trial of pembrolizumab in patients with advanced hematologic malignancies
Meeting Title: 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016)
Journal Title: Journal for ImmunoTherapy of Cancer
Volume: 4
Issue: Suppl. 1
Meeting Dates: 2016 Nov 9-13
Meeting Location: National Harbor, MD
ISSN: 2051-1426
Publisher: Biomed Central Ltd  
Date Published: 2016-11-16
Start Page: 82
Language: English
DOI: 10.1186/s40425-016-0172-7
PROVIDER: manual
PMCID: PMC5123387
Notes: Meeting Abstract: P142
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Craig Moskowitz
    407 Moskowitz